Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Are environmental factors for atopic eczema in ISAAC Phase Three due to reverse causation?

Rutter C, Silverwood RJ, Williams HC, Ellwood P, Asher I, Garcia-Marcos L, Strachan DP, Pearce N, Langan SM; ISAAC Phase Three Study Group, Aït-Khaled N, Anderson HR, Asher MI, Beasley R, Björkstén B, Brunekreef B, Crane J, Ellwood P, Flohr C, Forastiere F, García-Marcos L, Foliaki S, Keil U, Lai CKW, Mallol J, Robertson CF, Mitchell EA, Montefort S, Odhiambo J, Pearce N, Shah J, Stewart AW, Strachan D, von Mutius E, Weiland SK, Weinmayr G, Williams H, Wong G.

J Invest Dermatol. 2018 Dec 3. pii: S0022-202X(18)32812-4. doi: 10.1016/j.jid.2018.08.035. [Epub ahead of print]

PMID:
30521836
2.

Are environmental risk factors for current wheeze in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three due to reverse causation?

Silverwood RJ, Rutter CE, Mitchell EA, Asher MI, Garcia Marcos L, Strachan DP, Pearce N; ISAAC Phase Three Study Group.

Clin Exp Allergy. 2018 Dec 3. doi: 10.1111/cea.13325. [Epub ahead of print]

PMID:
30508327
3.

Ethnic Disparity in the Incidence and Outcome of Biliary Atresia in New Zealand.

Evans HM, Asher MI, Cameron-Christie S, Farthing S, McCall J, Robertson SP, Wong H, Morreau PN.

J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):218-221. doi: 10.1097/MPG.0000000000001781.

PMID:
29036008
4.

The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.

Ellwood P, Asher MI, Billo NE, Bissell K, Chiang CY, Ellwood EM, El-Sony A, García-Marcos L, Mallol J, Marks GB, Pearce NE, Strachan DP.

Eur Respir J. 2017 Jan 11;49(1). pii: 1601605. doi: 10.1183/13993003.01605-2016. Print 2017 Jan.

5.

Can geodata be used to determine the distribution of fast food outlets in relation to the prevalence and severity of asthma? A novel methodology.

Sheth A, Asher MI, Ellwood P, Ellwood E; ISAAC Phase Three Study Group.

Allergol Immunopathol (Madr). 2016 Jul-Aug;44(4):307-13. doi: 10.1016/j.aller.2015.07.003. Epub 2015 Nov 14.

PMID:
26589338
6.

Cooking fuels and prevalence of asthma: a global analysis of phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).

Wong GW, Brunekreef B, Ellwood P, Anderson HR, Asher MI, Crane J, Lai CK; ISAAC Phase Three Study Group.

Lancet Respir Med. 2013 Jul;1(5):386-94. doi: 10.1016/S2213-2600(13)70073-0. Epub 2013 May 31. Erratum in: Lancet Respir Med. 2013 Jul;1(5):358.

PMID:
24429203
7.

Time trends, ethnicity and risk factors for eczema in New Zealand children: ISAAC Phase Three.

Clayton T, Asher MI, Crane J, Ellwood P, Mackay R, Mitchell EA, Moyes CD, Pattemore P, Pearce N, Stewart AW.

Asia Pac Allergy. 2013 Jul;3(3):161-78. doi: 10.5415/apallergy.2013.3.3.161. Epub 2013 Jul 30.

8.

Heated humidification improves clinical outcomes, compared to a heat and moisture exchanger in children with tracheostomies.

McNamara DG, Asher MI, Rubin BK, Stewart A, Byrnes CA.

Respir Care. 2014 Jan;59(1):46-53. doi: 10.4187/respcare.02214. Epub 2013 Jun 13.

9.

How are 'urban' and 'rural' defined in publications regarding asthma and related diseases?

Lim A, Asher MI, Ellwood E, Ellwood P, Exeter DJ.

Allergol Immunopathol (Madr). 2014 Mar-Apr;42(2):157-61. doi: 10.1016/j.aller.2013.02.009. Epub 2013 Jun 2. Review.

PMID:
23735168
10.

Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three.

Ellwood P, Asher MI, García-Marcos L, Williams H, Keil U, Robertson C, Nagel G; ISAAC Phase III Study Group.

Thorax. 2013 Apr;68(4):351-60. doi: 10.1136/thoraxjnl-2012-202285. Epub 2013 Jan 14.

PMID:
23319429
11.

Time trends and risk factors for rhinoconjunctivitis in New Zealand children: an International Study of Asthma and Allergies in Childhood (ISAAC) survey.

Moyes CD, Clayton T, Pearce N, Asher MI, Ellwood P, Mackay R, Mitchell E, Pattemore P, Stewart AW, Crane J.

J Paediatr Child Health. 2012 Oct;48(10):913-20. doi: 10.1111/j.1440-1754.2012.02518.x. Epub 2012 Aug 17.

PMID:
22897723
12.

The challenges of replicating the methodology between Phases I and III of the ISAAC programme.

Ellwood P, Asher MI, Stewart AW, Aït-Khaled N, Mallol J, Strachan D; ISAAC Phase III Time Trends Study Group.

Int J Tuberc Lung Dis. 2012 May;16(5):687-93. doi: 10.5588/ijtld.11.0226.

PMID:
22507933
13.

Changes over time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: a global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC).

Asher MI, Stewart AW, Wong G, Strachan DP, García-Marcos L, Anderson HR; ISAAC Phase Three Study Group.

Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):267-74. doi: 10.1016/j.aller.2011.11.004. Epub 2012 Jan 31.

PMID:
22297190
14.

Urbanisation, asthma and allergies.

Asher MI.

Thorax. 2011 Dec;66(12):1025-6. doi: 10.1136/thoraxjnl-2011-201019. Epub 2011 Sep 22. No abstract available.

15.

The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis.

Dunstan JA, Brothers S, Bauer J, Hodder M, Jaksic MM, Asher MI, Prescott SL.

Clin Exp Immunol. 2011 Jun;164(3):321-9. doi: 10.1111/j.1365-2249.2011.04371.x. Epub 2011 Mar 17.

16.

Primary health care funding for children under six years of age in New Zealand: why is this so hard?

Fancourt N, Turner N, Asher MI, Dowell T.

J Prim Health Care. 2010 Dec 1;2(4):338-42.

PMID:
21125078
17.

The impact of the method of consent on response rates in the ISAAC time trends study.

Ellwood P, Asher MI, Stewart AW; ISAAC Phase III Study Group.

Int J Tuberc Lung Dis. 2010 Aug;14(8):1059-65.

PMID:
20626953
18.

Recent perspectives on global epidemiology of asthma in childhood.

Asher MI.

Allergol Immunopathol (Madr). 2010 Mar-Apr;38(2):83-7. doi: 10.1016/j.aller.2009.11.002. Epub 2010 Jan 27.

PMID:
20106581
19.

Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One.

Asher MI, Stewart AW, Mallol J, Montefort S, Lai CK, Aït-Khaled N, Odhiambo J; ISAAC Phase One Study Group.

Respir Res. 2010 Jan 21;11:8. doi: 10.1186/1465-9921-11-8. Review.

20.

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI; ISAAC Phase Three Study Group.

J Allergy Clin Immunol. 2009 Dec;124(6):1251-8.e23. doi: 10.1016/j.jaci.2009.10.009.

PMID:
20004783
21.

The prevalence of atopic symptoms in children with otitis media with effusion.

Souter MA, Mills NA, Mahadevan M, Douglas G, Ellwood PE, Asher MI, Clayton TO, Douglas RG.

Otolaryngol Head Neck Surg. 2009 Jul;141(1):104-7. doi: 10.1016/j.otohns.2009.03.007.

PMID:
19559967
22.

Diet and asthma: looking back, moving forward.

Kim JH, Ellwood PE, Asher MI.

Respir Res. 2009 Jun 12;10:49. doi: 10.1186/1465-9921-10-49.

23.

Cross-sectional survey of risk factors for asthma in 6-7-year-old children in New Zealand: International Study of Asthma and Allergy in Childhood Phase Three.

Mitchell EA, Stewart AW, Clayton T, Asher MI, Ellwood P, Mackay R, Moyes C, Pattemore PK, Pearce N.

J Paediatr Child Health. 2009 Jun;45(6):375-83. doi: 10.1111/j.1440-1754.2009.01504.x. Epub 2009 May 28.

PMID:
19490406
24.

Ethnic differences in time trends in asthma prevalence in New Zealand: ISAAC Phases I and III.

Ellison-Loschmann L, Pattemore PK, Asher MI, Clayton TO, Crane J, Ellwood P, Mackay RJ, Mitchell EA, Moyes C, Pearce N, Stewart AW.

Int J Tuberc Lung Dis. 2009 Jun;13(6):775-82.

PMID:
19460256
25.

Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial.

Brothers S, Asher MI, Jaksic M, Stewart AW.

Clin Exp Dermatol. 2009 Oct;34(7):770-5. doi: 10.1111/j.1365-2230.2008.03153.x. Epub 2009 Apr 27.

PMID:
19438539
26.
27.

Living in the country and studying in the city. The art of passing exams and remaining sane.

Grant CC, Pinnock R, Asher MI, Sullivan MJ.

J Paediatr Child Health. 2008 Oct;44(10):536-40. doi: 10.1111/j.1440-1754.2008.01382.x.

PMID:
19012626
28.

Has the prevalence and severity of symptoms of asthma changed among children in New Zealand? ISAAC Phase Three.

Asher MI, Stewart AW, Clayton T, Crane J, Ellwood PI, Mackay R, Mitchell E, Moyes C, Pattemore PK, Pearce N.

N Z Med J. 2008 Oct 17;121(1284):52-63.

PMID:
18953387
29.

International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children.

Anderson HR, Gupta R, Kapetanakis V, Asher MI, Clayton T, Robertson CF, Strachan DP; ISAAC Steering Committee.

Int J Epidemiol. 2008 Jun;37(3):573-82. doi: 10.1093/ije/dyn039. Epub 2008 Mar 13.

PMID:
18343854
30.

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys.

Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC Phase Three Study Group.

Lancet. 2006 Aug 26;368(9537):733-43. Erratum in: Lancet. 2007 Sep 29;370(9593):1128.

PMID:
16935684
31.

The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods.

Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW; ISAAC Steering Committee.

Int J Tuberc Lung Dis. 2005 Jan;9(1):10-6.

PMID:
15675544
32.

Asthma prevalence in European, Maori, and Pacific children in New Zealand: ISAAC study.

Pattemore PK, Ellison-Loschmann L, Asher MI, Barry DM, Clayton TO, Crane J, D'Souza WJ, Ellwood P, Ford RP, Mackay RJ, Mitchell EA, Moyes C, Pearce N, Stewart AW; ISAAC Study.

Pediatr Pulmonol. 2004 May;37(5):433-42.

PMID:
15095327
33.

Agreement between written and video questions for comparing asthma symptoms in ISAAC.

Crane J, Mallol J, Beasley R, Stewart A, Asher MI; International Study of Asthma and Allergies in Childhood Phase I study group.

Eur Respir J. 2003 Mar;21(3):455-61.

34.

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

Edwards EA, Asher MI, Byrnes CA.

J Paediatr Child Health. 2003 Mar;39(2):111-7.

PMID:
12603799
35.

A review of cough in children.

Chang AB, Asher MI.

J Asthma. 2001 Jun;38(4):299-309. Review.

PMID:
11456383
36.

Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood.

Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Björkstén B, Asher MI; ISAAC Phase 1 Study Group.

Am J Public Health. 2001 Jul;91(7):1126-9.

38.

The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One.

Asher MI, Barry D, Clayton T, Crane J, D'Souza W, Ellwood P, Ford RP, Mackay R, Mitchell EA, Moyes C, Pattemore P, Pearce N, Stewart AW; International Study of Asthma and Allergies in Childhood (ISAAC) Phase One.

N Z Med J. 2001 Mar 23;114(1128):114-20.

PMID:
11346157
39.

Current controversies: sinus disease and the lower airways.

Campanella SG, Asher MI.

Pediatr Pulmonol. 2001 Feb;31(2):165-72.

PMID:
11180693
40.

Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma.

Leversha AM, Campanella SG, Aickin RP, Asher MI.

J Pediatr. 2000 Apr;136(4):497-502.

PMID:
10753248
41.

Subpleural lung cysts in Down's syndrome.

Tyrrell VJ, Asher MI, Chan Y.

Pediatr Pulmonol. 1999 Aug;28(2):145-8. No abstract available.

PMID:
10423315
42.

Intake of trans fatty acids and prevalence of childhood asthma and allergies in Europe. ISAAC Steering Committee.

Weiland SK, von Mutius E, Hüsing A, Asher MI.

Lancet. 1999 Jun 12;353(9169):2040-1. No abstract available.

PMID:
10376626
43.

The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee.

Asher MI, Weiland SK.

Clin Exp Allergy. 1998 Nov;28 Suppl 5:52-66; discussion 90-1.

PMID:
9988448
44.

Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC).

Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Robertson C, Shah J, Stewart A, von Mutius E, Williams H.

Pediatr Allergy Immunol. 1997 Nov;8(4):161-76.

PMID:
9553981
45.

Erratum: Prevalence, severity and medical management of asthma in European children.

Mitchell EA, Asher MI.

J Paediatr Child Health. 1997 Apr;33(2):177. No abstract available.

PMID:
9235045
46.

The effect of season-of-response to ISAAC questions about asthma, rhinitis and eczema in children.

Stewart AW, Asher MI, Clayton TO, Crane J, D'Souza W, Ellwood PE, Ford RP, Mitchell EA, Pattemore PK, Pearce N.

Int J Epidemiol. 1997 Feb;26(1):126-36.

PMID:
9126512
47.

Measuring morbidity from asthma in children.

Mitchell EA, Stewart AW, Rea HH, McNaughton S, Taylor G, Smith LT, Asher MI, Mulder J, Seelye ER.

N Z Med J. 1997 Jan 24;110(1036):3-6.

PMID:
9059450
48.

Proposals for standards of cystic fibrosis management in New Zealand. A position statement by the Respiratory Committee of the Paediatric Society of New Zealand.

Wesley AW, Asher MI, Gillies JD, Pattemore PK, Kerr A, Hewitt C.

N Z Med J. 1996 Apr 26;109(1020):140-1. No abstract available.

PMID:
8649669
49.

Update on spacer devices in childhood asthma.

Leversha AM, Asher MI.

N Z Med J. 1996 Mar 8;109(1017):76-8. No abstract available.

PMID:
8606824
50.

Management of the wheezy infant. The Respiratory Committee of the Paediatric Society of New Zealand.

Gillies JD, Pattemore PK, Asher MI.

N Z Med J. 1996 Jan 26;109(1014):14-5. Review. No abstract available.

PMID:
8628526

Supplemental Content

Loading ...
Support Center